But it’s up to your specific plan to decide whether it covers a certain insulin drug, such as Basaglar. Basaglar is a long-acting insulin medication delivered through insulin pens called KwikPens.
The Basaglar NDA was filed through the FDA's 505(b)(2) regulatory pathway, which allows the agency to consider the efficacy and safety of the existing insulin glargine product.
Some Medicare plans may cover Basaglar, but it varies by plan. Learn which plans cover Basaglar, how to find coverage, and what you can expect to pay.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback